J&J Puts Pharma Group Into Review

NEW YORK (AdAge.com) — Johnson & Johnson has kicked off a soup-to-nuts review for its $25 billion pharmaceuticals group.

No Responses to “J&J Puts Pharma Group Into Review”

Post a Comment